Dimensional Fund Advisors’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
WC
NCNMGF
FCM
SAM
KCM
MBAM
Dimensional Fund Advisors's XGN Position: Q2 2026 in Review
Dimensional Fund Advisors held its Exagen (XGN) position steady in Q2 2026 at 62,571 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #3035.
Dimensional Fund Advisors first reported a position in XGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $579K in Q1 2022. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.
- Dimensional Fund Advisors held 62,571 shares of Exagen worth $291K as of Q2 2026.
- Dimensional Fund Advisors left its Exagen share count unchanged in Q2 2026.
- Exagen made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3035 holding.
- Dimensional Fund Advisors first reported a position in Exagen in Q2 2021 and has held it in 20 quarters since.
- Dimensional Fund Advisors's Exagen position peaked at $579K in Q1 2022.
- 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.